The global blood clot retrieval devices market is driven by the advancement in technology and growing prevalence of stroke. However, lack of skilled professionals and fruitless root canal procedures occurring due to unfavorable results and failure of device during the blood clot retrieval, are some limitations faced by the blood clot retrieval devices market. The overall market growth is projected to witness a double-digit CAGR for the forecast period. On the basis of stroke type, the global market is segmented as ischemic stroke, hemorrhagic stroke, transient ischemic attack. On the basis of stroke type, the global blood clot retrieval equipment market is segmented as mechanical embolus removal devices, penumbra blood clot retrieval devices, stent retrievers, and ultrasound-assisted devices.
A person suffers from a stroke when insufficient blood flow results in cell death. Strokes are of two types, ischemic and hemorrhagic. Ischemic is due to lack of blood flow and hemorrhagic is due to internal bleeding. Under such conditions, the brain may not work well. Inability to move, feeling only one side of the body, understanding problems, speech problems, dizziness, loss of vision, etc. are some major symptoms associated with blood clotting. Risk factors interlinked with blood clotting include high blood pressure, obesity, high blood cholesterol, tobacco, diabetes mellitus, and smoking. Causes of ischemic blood clot involve blockage of a blood vessel whereas a hemorrhagic stroke involves direct bleeding into the brain or into the space surrounding the brain. Brain aneurysm causes bleeding and diagnosis typically involves medical resonance imaging (MRI) scan and electrocardiogram (ECG). Blood tests are conducted in order to determine risk factors and understand the root problems.
In order to cope up with the increasing prevalence of blood clot incidences, the devices namely Mechanical Embolus Removal in Cerebral Ischemia (MERCI) was produced. MERCI is capable to deal with cases involving moderate to severe stroke. Another device namely Penumbra clot aspiration system used a large lumen attached to a vacuum pump for removal of the clot. The fundamental objective of these clot removing devices was to help in coiling during the refurbishing of cells in patients.
On the basis of end-user, the global blood clot retrieval devices market is segmented into hospitals, clinics, diagnostic centers, and ambulatory surgical centers. On the basis of geographic segmentation, the global blood clot retrieval equipment market spans North America, Europe, Middle-East, Asia-Pacific excluding Japan, Japan, and Africa. North America dominates the global market owing to favorable reimbursement and advanced development for diagnostic procedures. APEJ regions are growing steadily as local players are emerging rapidly in the blood clot retrieval devices.
The key market players in the global blood clot retrieval devices market include Boston Scientific Corp., Bayer HealthCare LLC, Medtronic plc. Argon Medical Devices Inc., Teleflex Incorporated, Penumbra Inc., AngioDynamics, Inc., Johnson and Johnson, Inc., Terumo Corporation, ECKOS Corporation.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.